Xior Student Housing NV

ENXTBR:XIOR Stock Report

Market Cap: €1.3b

Xior Student Housing Valuation

Is XIOR undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

6/6

Valuation Score 6/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of XIOR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: XIOR (€29.75) is trading below our estimate of fair value (€39.72)

Significantly Below Fair Value: XIOR is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for XIOR?

Key metric: As XIOR is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for XIOR. This is calculated by dividing XIOR's market cap by their current revenue.
What is XIOR's PS Ratio?
PS Ratio6.1x
Sales€205.81m
Market Cap€1.27b

Price to Sales Ratio vs Peers

How does XIOR's PS Ratio compare to its peers?

The above table shows the PS ratio for XIOR vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average7.9x
CPINV Care Property Invest
6.4x3.9%€446.8m
HOMI Home Invest Belgium
8.3x2.8%€313.3m
MONT Montea Comm. VA
10.8x8.9%€1.5b
RET Retail Estates
6.1x4.7%€857.4m
XIOR Xior Student Housing
6.1x-0.7%€1.3b

Price-To-Sales vs Peers: XIOR is good value based on its Price-To-Sales Ratio (6.1x) compared to the peer average (7.9x).


Price to Sales Ratio vs Industry

How does XIOR's PS Ratio compare vs other companies in the European Residential REITs Industry?

1 CompanyPrice / SalesEstimated GrowthMarket Cap
XIOR 6.1xIndustry Avg. 8.9xNo. of Companies5PS0612182430+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: XIOR is good value based on its Price-To-Sales Ratio (6.1x) compared to the European Residential REITs industry average (8.9x).


Price to Sales Ratio vs Fair Ratio

What is XIOR's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

XIOR PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio6.1x
Fair PS Ratio6.3x

Price-To-Sales vs Fair Ratio: XIOR is good value based on its Price-To-Sales Ratio (6.1x) compared to the estimated Fair Price-To-Sales Ratio (6.3x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst XIOR forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€29.75
€37.00
+24.4%
9.3%€42.00€31.00n/a9
Nov ’25€30.70
€37.00
+20.5%
9.3%€42.00€31.00n/a9
Oct ’25€34.20
€36.33
+6.2%
10.3%€40.00€30.00n/a9
Sep ’25€32.75
€34.89
+6.5%
11.3%€40.00€28.00n/a9
Aug ’25€31.35
€34.39
+9.7%
10.3%€38.00€28.00n/a9
Jul ’25€29.85
€33.72
+13.0%
12.7%€38.00€24.00n/a9
Jun ’25€28.50
€33.69
+18.2%
14.0%€39.00€24.00n/a8
May ’25€28.00
€33.69
+20.3%
14.0%€39.00€24.00n/a8
Apr ’25€28.00
€35.07
+25.3%
9.0%€39.00€30.00n/a7
Mar ’25€25.35
€35.36
+39.5%
9.1%€39.00€30.00n/a7
Feb ’25€27.15
€35.36
+30.2%
9.1%€39.00€30.00n/a7
Jan ’25€29.70
€35.00
+17.8%
11.2%€42.00€30.00n/a7
Dec ’24€31.45
€34.86
+10.8%
11.8%€42.00€29.00n/a7
Nov ’24€27.90
€34.83
+24.9%
12.7%€42.00€29.00€30.706
Oct ’24€27.10
€34.83
+28.5%
12.7%€42.00€29.00€34.206
Sep ’24€26.85
€34.83
+29.7%
12.7%€42.00€29.00€32.756
Aug ’24€27.70
€36.42
+31.5%
15.9%€44.00€29.00€31.356
Jul ’24€27.25
€36.38
+33.5%
12.9%€42.00€31.00€29.854
Jun ’24€28.15
€36.38
+29.2%
12.9%€42.00€31.00€28.504
May ’24€28.80
€36.38
+26.3%
12.9%€42.00€31.00€28.004
Apr ’24€31.00
€39.13
+26.2%
15.6%€48.00€31.00€28.004
Mar ’24€30.55
€39.63
+29.7%
13.7%€48.00€33.00€25.354
Feb ’24€31.30
€40.38
+29.0%
11.5%€48.00€36.00€27.154
Jan ’24€28.90
€47.70
+65.1%
20.5%€60.00€36.00€29.705
Dec ’23€27.25
€47.70
+75.0%
20.5%€60.00€36.00€31.455
Nov ’23€29.45
€52.40
+77.9%
17.0%€60.00€36.00€27.905

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies